Delivery systems for intradermal vaccination

Current Topics in Microbiology and Immunology

Volumn 351, Issue 1, 2012, Pages 77-112

  Kim, Y C ^a,b   Jarrahian, C ^c   Zehrung, D ^c   Mitragotri, S ^d   Prausnitz, M R ^a  

^a Georgia Institute of Technology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PATH   (United States)

^d University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; BCG VACCINE; CARBOXYMETHYLCELLULOSE; CHIMERI VAX; DEXTRIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DNA VACCINE; ESCHERICHIA COLI VACCINE; GOLD NANOPARTICLE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIVE VACCINE; MALTOSE; MEASLES VACCINE; POLIOMYELITIS VACCINE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYPHOSPHAZENE; POVIDONE; RABIES VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

ANTHRAX; ANTIBODY TITER; ARTICLE; BODY PIERCING; CHEMICAL ENHANCER; CHEMICAL PARAMETERS; COST EFFECTIVENESS ANALYSIS; DRUG ADMINISTRATION ROUTE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSE COMPARISON; DRUG RESPONSE; DRUG SOLUBILITY; ELECTROPORATION; ERADICATION THERAPY; ESCHERICHIA COLI INFECTION; GENE GUN IMMUNIZATION; HEPATITIS A; HEPATITIS B; HIGH TEMPERATURE PROCEDURES; HUMAN; IMMUNOGENICITY; INFLUENZA; INTRACUTANEOUS VACCINATION; JAPANESE ENCEPHALITIS; JET INJECTOR; MATERIAL COATING; MEASLES; MICRONEEDLE; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL; RABIES; SEROCONVERSION; SKIN ABRASION; SKIN PERMEABILITY; SKIN TEST; SMALLPOX; TATTOOING; TETANUS; THERMAL ABLATION; TICK BORNE ENCEPHALITIS; TRANSDERMAL PATCH; TUBERCULIN TEST; TUBERCULOSIS; ULTRASOUND TRANSDUCER; VACCINATION; YELLOW FEVER;

ABLATION TECHNIQUES; BACTERIAL INFECTIONS; DRUG DELIVERY SYSTEMS; ELECTROPORATION; HUMANS; IMMUNITY; INJECTIONS, INTRADERMAL; INJECTIONS, JET; NEEDLES; SKIN; VACCINATION; VACCINES; VIRUS DISEASES;

VARIOLA VIRUS;

EID: 80053551505     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82_2011_123     Document Type: Article

References (168)

1. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14:375-381 (Pubitemid 46732547)
2. Andrianov AK, DeCollibus DP, Gillis HA, Kha HH, Marin A, Prausnitz MR, Babiuk LA, Townsend H, Mutwiri G (2009) Poly [di (carboxylatophenoxy) phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci USA 106:18936-18941
3. Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P (2009) Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 27:7304-7312
4. Ayoola EA (1984) Hepatitis B vaccine in developing countries: problems and prospects. IARC Sci Publ 63:297-305
5. Babiuk S, Baca-Estrada ME, Foldvari M, Storms M, Rabussay D, Widera G, Babiuk LA (2002) Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20:3399-3408 (Pubitemid 35245823)
6. Baxby D (2002) Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine 20:2140-2149 (Pubitemid 34327787)
7. Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G (2004) Serum antibody responses after intradermal vaccination against influenza. New Engl J Med 351:2286-2294 (Pubitemid 39552744)
8. Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE (2007) Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 25:6755-6763 (Pubitemid 47332726)
9. Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, Demanet E, Heijmans S, Van Belle P, Weber F, Salamand C (2009) Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 7:13
10. Bernard KW, Roberts MA, Sumner J, Winkler WG, Mallonee J, Baer GM, Chaney R (1982) Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 247:1138-1142 (Pubitemid 12165685)
11. Bernard KW, Mallonee J, Wright JC, Reid FL, Makintubee S, Parker RA, Dwyer DM, Winkler WG (1987) Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination. JAMA 257:1059-1063 (Pubitemid 17031494)
12. Bilitewski U, Genrich M, Kadow S, Mersal G (2003) Biochemical analysis with microfluidic systems. Anal Bioanal Chem 377:556-569 (Pubitemid 40877876)
13. Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TNM, Haanen JBAG (2005) A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11:899-904 (Pubitemid 41161124)
14. Bramson J, Dayball K, Evelegh C, Wan YH, Page D, Smith A (2003) Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 10:251-260 (Pubitemid 36204414)
15. Bremseth DL, Pass F (2001) Delivery of insulin by jet injection: recent observations. Diabetes Technol Ther 3:225-232 (Pubitemid 32651958)
16. Brindle RJ, Morris CA, Berger R, Kurtz JB (1994) Inadequate response to intradermal hepatitis A vaccine. Vaccine 12:483-484 (Pubitemid 24122851)
17. Burland WL (1969) Measles vaccination by the intradermal route. Postgrad Med J 45:323-326
18. Carlsson U, Brudin L, Eliasson I, Hansson BG (1996) Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative. Scand J Infect Dis 28:435-438 (Pubitemid 26393581)
19. Chen W, Gluud C (2005) Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev, Issue 4. Art. No.: CD000100. doi:10.1002/14651858.CD000100.pub3
20. Chen D, Zuleger C, Chu Q, Maa YF, Osorio J, Payne LG (2002) Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses. AIDS Res Hum Retroviruses 18:715-722 (Pubitemid 34765340)
21. Chen D, Burger M, Chu Q, Endres R, Zuleger C, Dean H, Payne LG (2004) Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res 103:147-153 (Pubitemid 38649073)
22. Chen XF, Prow TW, Crichton ML, Jenkins DWK, Roberts MS, Frazer IH, Fernando GJP, Kendall MAF (2009) Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release 139:212-220
23. Coberly JS, Townsend T, Repke J, Fields H, Margolis H, Halsey NA (1994) Suboptimal response following intradermal hepatitis B vaccine in infants. Vaccine 12:984-987 (Pubitemid 24246868)
24. Cosman F, Lane NE, Bolognese MA, Zanchetta JR, Garcia-Hernandez PA, Sees K, Matriano JA, Gaumer K, Daddona PE (2009) Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 95:151-158
25. Dahlan A, Alpar HO, Stickings P, Sesardic D, Murdan S (2009) Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm 368:123-128
26. Darmanger AM, Nekzad SM, Kuis M, Tendam HG (1977) BCG vaccination by bifurcated needle in a pilot vaccination program. Bull WHO 55:49-61 (Pubitemid 8189282)
27. Davis SP, Martanto W, Allen MG, Prausnitz MR (2005) Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng 52:909-915 (Pubitemid 40675490)
28. de Moraes JC, Leon ME, Souza VA, Pannuti C, Travisanello C, Halsey NA, de Quadros CA (1994) Intradermal administration of measles vaccines. Bull Pan Am Health Organ 28:250-255
29. Dean HJ, Chen D (2004) Epidermal powder immunization against influenza. Vaccine 23:681-686 (Pubitemid 39473199)
30. Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, Monath TP, Mikszta JA (2005) Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccine 1:106-111
31. Dimache G, Stoean C, Durbaca S, Croitoru M, Ionescu M, Nedelcu IN, Corbu I (1990) Study of specific immune response to unadsorbed concentrated tetanus vaccine administered by intradermal route to non-immunized persons in the last ten years. Arch Roum Pathol Exp Microbiol 49:51-62
32. Ding Z, Van Riet E, Romeijn S, Kersten GFA, Jiskoot W, Bouwstra JA (2009a) Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res 26:1635-1643
33. Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, Kersten G, Bouwstra JA (2009b) Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release 136:71-78
34. Donnelly RF, Singh TRR, Tunney MM, Morrow DIJ, McCarron PA, O'Mahony C, Woolfson AD (2009) Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 26:2513-2522
35. Drabick JJ, Glasspool-Malone J, King A, Malone RW (2001) Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 3:249-255 (Pubitemid 32509828)
36. Drape RJ, Macklin MD, Barr LJ, Jones S, Haynes JR, Dean HJ (2006) Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 24:4475-4481 (Pubitemid 43776768)
37. Epstein JE, Gorak EJ, Charoenvit Y, Wang R, Freydberg N, Osinowo O, Richie TL, Stoltz EL, Trespalacios F, Nerges J, Ng J, Fallarme-Majam V, Abot E, Goh L, Parker S, Kumar S, Hedstrom RC, Norman J, Stout R, Hoffman SL (2002) Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes. Hum Gene Ther 13:1551-1560 (Pubitemid 35034675)
38. Eriksson E, Yao F, Svensjo T, Winkler T, Slama J, Macklin MD, Andree C, McGregor M, Hinshaw V, Swain WF (1998) In vivo gene transfer to skin and wound by microseeding. J Surg Res 78:85-91 (Pubitemid 28419216)
39. Etchart N, Hennino A, Friede M, Dahel K, Dupouy M, Goujon-Henry C, Nicolas JF, Kaiserlian D (2007) Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Vaccine 25:6891-6899 (Pubitemid 47391105)
40. Fernando GJP, Chen XF, Prow TW, Crichton ML, Fairmaid EJ, Roberts MS, Frazer IH, Brown LE, Kendall MAF (2010) Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One 5:e10266
41. Fishbein DB, Pacer RE, Holmes DF, Ley AB, Yager P, Tong TC (1987) Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study. J Infect Dis 156:50-55 (Pubitemid 17095028)
42. Flynn PM, Shenep JL, Mao L, Crawford R, Williams BF, Williams BG (1994) Influence of needle gauge in Mantoux skin testing. Chest 106:1463-1465 (Pubitemid 24346111)
43. Foldvari M, Babiuk S, Badea I (2006) DNA delivery for vaccination and therapeutics through the skin. Curr Drug Deliv 3:17-28
44. Frech SA, Kenney RT, Spyr CA, Lazar H, Viret JF, Herzog C, Gluck R, Glenn GM (2005) Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 23:946-950 (Pubitemid 39643184)
45. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Melendez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM (2008) Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 371:2019-2025
46. Frerichs DM, Ellingsworth LR, Frech SA, Flyer DC, Villar CP, Yu J, Glenn GM (2008) Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine 26:2782-2787
47. Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB (2002) Clinical responses to undiluted and diluted smallpox vaccine. New Engl J Med 346:1265-1274 (Pubitemid 34429457)
48. Gardeniers HJGE, Luttge R, Berenschot EJW, de Boer MJ, Yeshurun SY, Hefetz M, van't Oever R, van den Berg A (2003) Silicon micromachined hollow microneedles for transdermal liquid transport. J MEMS 12:855-862
49. Garg S, Hoelscher M, Belser JA, Wang C, Jayashankar L, Guo Z, Durland RH, Katz JM, Sambhara S (2007) Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin Vaccine Immunol 14:926-928
50. Gehl J (2008) Electroporation for drug and gene delivery in the clinic: doctors go electric. Methods Mol Biol 423:351-359
51. Gill HS, Prausnitz MR (2007a) Coated microneedles for transdermal delivery. J Control Release 117:227-237 (Pubitemid 46161873)
52. Gill HS, Prausnitz MR (2007b) Coating formulations for microneedles. Pharm Res 24:1369-1380 (Pubitemid 46870599)
53. Gill HS, Prausnitz MR (2008) Pocketed microneedles for drug delivery to the skin. J Phys Chem Solids 69:1537-1541
54. Gill HS, Andrews SN, Sakthivel SK, Fedanov A, Williams IR, Garber DA, Priddy FH, Yellin S, Feinberg MB, Staprans SI, Prausnitz MR (2009) Selective removal of stratum corneum by microdermabrasion to increase skin permeability. Eur J Pharm Sci 38:95-103
55. Gill HS, Sõderholm J, Prausnitz MR, Sällberg M (2010) Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther 17:811-814
56. Glenn GM, Kenney RT (2006) Mass vaccination: solutions in the skin. Curr Top Microbiol Immunol 304:247-268 (Pubitemid 47413300)
57. Gomez V, Palomeque FS, Feris J et al. (2010) Still-blinded safety and immunogenicity data from a trial of reduced-dose, intradermal, influenza vaccination by needle-free jet injection. 13th Annual Conference on Vaccine Research, Bethesda, MD
58. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24:1159-1169 (Pubitemid 43202262)
59. Guebre-Xabier M, Hammond SA, Epperson DE, Yu J, Ellingsworth L, Glenn GM (2003) Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol 77:5218-5225 (Pubitemid 36460936)
60. Han M, Kim DK, Kang SH, Yoon HR, Kim BY, Lee SS, Kim KD, Lee HG (2009) Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array. Sens Act B 137:274-280
61. Heijtink RA, Knol RM, Schalm SW (1989) Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes. J Med Virol 27:151-154 (Pubitemid 19078728)
62. Henderson DA, Borio BL, Grabenstein JD (2008) Smallpox and vaccinia. In: Plotkin S, Orenstein WA, Offit PA (eds) Vaccines, vol 5. Elsevier, Amsterdam, pp 773-803
63. Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA (2008) A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198:1491-1501
64. Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M (2008) Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 198:650-658
65. Howard A, Mercer P, Nataraj HC, Kang BC (1997) Bevel-down superior to bevel-up in intradermal skin testing. Ann Allergy Asthma Immunol 78:594-596 (Pubitemid 27264195)
66. Inoue J, Aramaki Y (2007) Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG- oligodeoxynucleotides. Vaccine 25:1007-1013 (Pubitemid 44937458)
67. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K (2006) Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 29:82-88 (Pubitemid 44279397)
68. Jones S, Evans K, McElwaine-Johnn H, Sharpe M, Oxford J, Lambkin-Williams R, Mant T, Nolan A, Zambon M, Ellis J, Beadle J, Loudon PT (2009) DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. Vaccine 27:2506-2512
69. Kalluri H, Banga AK (2011) Formation and closure of microchannels in skin following microporation. Pharm Res 28:82-94
70. Karande P, Jain A, Mitragotri S (2004) Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 22:192-197 (Pubitemid 38160534)
71. Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S (2005) Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688-4693 (Pubitemid 40471515)
72. Karande P, Arora A, Pham TK, Stevens D, Wojicki A, Mitragotri S (2009) Transcutaneous immunization using common chemicals. J Control Release 138:134-140
73. Kermode M (2004) Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int 19:95-103 (Pubitemid 38364808)
74. Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR (2009) Improved influenza vaccination in the skin using vaccine coated-microneedles. Vaccine 27:6932-6938
75. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2010a) Fomulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech 11:1193-1201
76. Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR (2010b) Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis 201:190-198
77. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2010c) Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunoge-nicity. J Control Release 142:187-195
78. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2011) Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res 28:135-144
79. Kok PW, Kenya PR, Ensering H (1983) Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration. Trans Roy Soc Trop Med Hyg 77:171-176 (Pubitemid 13052565)
80. Kolli CS, Banga AK (2008) Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 25:104-113
81. Koutsonanos DG, Martin MdP, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, Skountzou I (2009) Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4:e4773
82. Laddy DJ, Yan J, Khan AS, Andersen H, Cohn A, Greenhouse J, Lewis M, Manischewitz J, King LR, Golding H, Draghia-Akli R, Weiner DB (2009) Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 83:4624-4630
83. Lambert PH, Laurent PE (2008) Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26:3197-3208
84. Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG (2007) Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25:8833-8842 (Pubitemid 350192056)
85. Lee JW, Park JH, Prausnitz MR (2008) Dissolving microneedles for transdermal drug delivery. Biomaterials 29:2113-2124
86. Lee K, Lee HC, Lee DS, Jung H (2010) Drawing lithography: three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle. Adv Mat 22:483-486
87. Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, Leroux-Roels G (2008) Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 26:6614-6619
88. Luttge R, Berenschot EJW, de Boer MJ, Altpeter DM, Vrouwe EX, van den Berg A, Elwenspoek M (2007) Integrated lithographic molding for microneedle-based devices. J MEMS 16:872-884 (Pubitemid 47278830)
89. Mantoux C (1909) Tuberculin intradermo reactions in the treatment of tuberculosis: intradermi-tuberculisation. C R Hebd Seances Acad Sci 148:996-998
90. Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, Daddona PE (2002) Macroflux® microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 19:63-70 (Pubitemid 34075108)
91. Matyas GR, Friedlander AM, Glenn GM, Little S, Yu J, Alving CR (2004) Needle-free skin patch vaccination method for anthrax. Infect Immun 72:1181-1183 (Pubitemid 38166706)
92. Medi BM, Singh J (2008) Delivery of DNA into skin via electroporation. Methods Mol Biol 423:225-232
93. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG (2002) Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8:415-419 (Pubitemid 34407039)
94. Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP, Brittingham JM, Huang J, Hwang CR, Ferriter M, Jiang G, Mar K, Saikh KU, Stiles BG, Roy CJ, Ulrich RG, Harvey NG (2005) Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis 191:278-288 (Pubitemid 40096387)
95. Mikszta JA, Dekker JP, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG (2006) Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 74:6806-6810 (Pubitemid 44913155)
96. Millar JD, Foege WH (1969) Status of eradication of smallpox (and control of measles) in West and Central Africa. J Infect Dis 120:725-732
97. Miller MA, Pisani E (1999) The cost of unsafe injections. Bull WHO 77:808-811
98. Milne A, Allwood GK, Pearce NE, Lucas CR, Krugman S (1986) Low dose hepatitis B vaccination in children. New Zeal Med J 99:47-49 (Pubitemid 16141558)
99. Mitragotri S (2005) Immunization without needles. Nat Rev Immun 5:905-916 (Pubitemid 41746760)
100. Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MMA, Sharif SM, van der Avoort HGAM, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW (2010) Fractional doses of inactivated poliovirus vaccine in Oman. New Engl J Med 362:2351-2359
101. Ng KW, Pearton M, Coulman S, Anstey A, Gateley C, Morrissey A, Allender C, Birchall J (2009) Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Vaccine 27:5948-5955
102. Nicolas JF, Guy B (2008) Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 7:1201-1214
103. Nirmal S, Cherian T, Samuel BU, Rajasingh J, Raghupathy P, John TJ (1998) Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine. Vaccine 16:928-931 (Pubitemid 28276003)
104. Oh SJ, Harrison T, D'Andrea A, Kwon SY, Burkoth TL, Burke R (2006) Intradermal influenza vaccine delivery using skin-penetrating dissolvable vaccine microneedles. AAPS Annual Meeting. San Antonio, TX
105. Oosterhuis K, Van den Berg JH, Schumacher TN, Haanen JBAG (2011) DNA vaccines and intradermal vaccination by DNA tattooing. Curr Top Microbiol Immunol (this issue)
106. Osorio JE, Zuleger CL, Burger M, Chu Q, Payne LG, Chen D (2003) Immune responses to hepatitis B surface antigen following epidermal powder immunization. Immunol Cell Biol 81:52-58 (Pubitemid 36237792)
107. Pancharoen C, Mekmullica J, Thisyakorn U, Kasempimolporn S, Wilde H, Herzog C (2005) Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs. Clin Infect Dis 41:1537-1540 (Pubitemid 41580003)
108. Park JH, Allen MG, Prausnitz MR (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 104:51-66 (Pubitemid 40615235)
109. Park JH, Allen MG, Prausnitz MR (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res 23:1008-1019 (Pubitemid 43781409)
110. Parker V (1984) Jet gun or syringe? A trial of alternative methods of BCG vaccination. Public Health 98:315-320 (Pubitemid 15182619)
111. PATH (2009) Intradermal delivery of vaccines: a review of the literature and the potential for development for use in low-and middle-income countries. PATH/WHO, Ferney Voltaire, France. http://www.path.org/publications/detail.php? i=1746 14 Sept 2010.
112. Paul SS, Raveendra NK, Chhabra AK, Verma M (1978) Comparison of BCG inoculation by conventional intradermal and jet methods. Indian Pediatr 15:341-347 (Pubitemid 9113847)
113. Peachman KK, Rao M, Alving CR (2003) Immunization with DNA through the skin. Methods 31:232-242 (Pubitemid 37162796)
114. Perennes F, Marmiroli B, Matteucci M, Tormen M, Vaccari L, Di Fabrizio E (2006) Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J Micromech Microeng 16:473-479 (Pubitemid 43289723)
115. Phanuphak P, Khaoplod P, Benjavongkulchai M, Chutivongse S, Wilde H (1990) What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously? Bull WHO 68:83-85 (Pubitemid 20153774)
116. Plotkin S, Orenstein W, Offit P (eds) (2008) Vaccines. Saunders, Philadelphia
117. Pokorna D, Polakova I, Kindlova M, Duskova M, Ludvikova V, Gabriel P, Kutinova L, Muller M, Smahel M (2009) Vaccination with human papillomavirus type 16-derived peptides using a tattoo device. Vaccine 27:3519-3529
118. Potthoff A, Schwannecke S, Nabi G, Hoffmann D, Grunwald T, Wildner O, Brockmeyer NH, Uberla K, Tenbusch M (2009) Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine 27:2768-2774
119. Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581-587 (Pubitemid 38326934)
120. Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261-1268
121. Prausnitz MR, Bose VG, Langer R, Weaver JC (1993) Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504-10508 (Pubitemid 23347070)
122. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK (2009) Microneedle-based vaccines. Curr Top Microbiol Immunol 333:369-393
123. Quaak SGL, van den Berg JH, Toebes M, Schumacher TNM, Haanen J, Beijnen JH, Nuijen B (2008) GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial. Eur J Pharm Biopharm 70:429-438
124. Quaak SGL, den Berg JHv, Oosterhuis K, Beijnen JH, Haanen JBAG, Nuijen B (2009) DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms. J Control Release 139:153-159
125. Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, Kang SM (2009) Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 4:e7152
126. Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, Prausnitz MR, Compans RW, Kang SM (2010) Intradermal vaccination with influenza VLPs using microneedles induces superior protection to intramuscular immunization. J Virol 84:7760-7769
127. Rahman F, Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF (2000) Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 31:521-527 (Pubitemid 30078622)
128. Resik S, Tejeda A, Lago PM, Diaz M, Carmenates A, Sarmiento L, Alemani N, Galindo B, Burton A, Friede M, Landaverde M, Sutter RW (2010) Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. J Infect Dis 201:1344-1352
129. Roberts LK, Barr LJ, Fuller DH, McMahon CW, Leese PT, Jones S (2005) Clinical safety and efficacy of a powdered hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23:4867-4878 (Pubitemid 41242881)
130. Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG (2008) Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS One 3:e1993
131. Roukens AHE, Gelinck LBS, Visser LG (2011) Intradermal vaccination to protect against yellow fever and influenza. Curr Top Microbiol Immunol (this issue)
132. Roxhed N, Gasser TC, Griss P, Holzapfel GA, Stemme G (2007) Penetration-enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery. J MEMS 16:1429-1440 (Pubitemid 350239136)
133. Roy MJ, Wu MS, Barr LJ, Fuller JT, Tussey LG, Speller S, Culp J, Burkholder JK, Swain WF, Dixon RM, Widera G, Vessey R, King A, Ogg G, Gallimore A, Haynes JR, Heydenburg Fuller D (2000) Induction of antigen-specific CD8 T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19:764-778
134. Samuel BU, Cherian T, Sridharan G, Mukundan P, John TJ (1991) Immune response to intradermally injected inactivated poliovirus vaccine. Lancet 338:343-344
135. Samuel BU, Cherian T, Rajasingh J, Raghupathy P, John TJ (1992) Immune response of infants to inactivated poliovirus vaccine injected intradermally. Vaccine 10:135
136. Sangare L, Manhart L, Zehrung D, Wang CC (2009) Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine 27:1777-1786
137. Scheuplein RJ, Blank IH (1971) Permeability of the skin. Physiol Rev 51:702-747
138. Schramm-Baxter J, Mitragotri S (2004) Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power. J Control Release 97:527-535 (Pubitemid 38802954)
139. Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM (2006) Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24:6110-6119 (Pubitemid 44175614)
140. Stanfield JP, Bracken PM, Waddell KM, Gall D (1972) Diphtheria-tetanus- pertussis immunization by intradermal jet injection. Brit Med J 2:197-199
141. Sullivan SP, Murthy N, Prausnitz MR (2008) Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mat 20:933-938
142. Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16:915-920
143. Sutter R (2009) Status of GPEI research and product development. Manufacturer's Meeting, Geneva 30 Oct 2009.
144. Takigawa M, Tokura Y, Hashizume H, Yagi H, Seo N (2001) Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Ann N Y Acad Sci 941:139-146 (Pubitemid 32928340)
145. Tang H, Wang CC, Blankschtein D, Langer R (2002) An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res 19:1160-1169 (Pubitemid 34985000)
146. Tezel A, Mitragotri S (2003) Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys J 85:3502-3512 (Pubitemid 37490266)
147. Tezel A, Sens A, Tuchscherer J, Mitragotri S (2001) Frequency dependence of sonophoresis. Pharm Res 18:1694-1700 (Pubitemid 34020424)
148. Tezel A, Sens A, Mitragotri S (2002) Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J Pharm Sci 91:444-453 (Pubitemid 34137366)
149. Tezel A, Paliwal S, Shen Z, Mitragotri S (2005) Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23:3800-3807 (Pubitemid 40704743)
150. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y (2009) Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27:454-459
151. Van den Berg JH, Nuijen B, Beijnen JH, Vincent A, Van Tinteren H, Kluge J, Woerdeman LAE, Hennink WE, Storm G, Schumacher TN, Haanen J (2009) Optimization of intradermal vaccination by DNA tattooing in human skin. Human Gene Ther 20:181-189
152. Van Kampen KR, Shi Z, Gao P, Zhang J, Foster KW, Chen DT, Marks D, Elmets CA, Tang DC (2005) Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23:1029-1036 (Pubitemid 40037652)
153. Vandermeulen G, Daugimont L, Richiardi H, Vanderhaeghen ML, Lecouturier N, Ucakar B, Preat V (2009) Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation. Pharm Res 26:1745-1751
154. Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC, Sattentau Q, Wagner R, Wolf H, Schumacher TNM, Heeney JL, Haanen JBAG (2008) Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 26:3346-3351
155. Wang PM, Cornwell M, Hill J, Prausnitz MR (2006) Precise microinjection into skin using hollow microneedles. J Invest Dermatol 126:1080-1087
156. Wang PC, Wester BA, Rajaraman S, Paik SJ, Kim SH, Allen MG (2009) Hollow polymer microneedle array fabricated by photolithography process combined with micromolding technique. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Minneapolis, pp 7026-7029
157. Warrell MJ (2011) Intradermal rabies vaccination: the evolution and future of pre-and post-exposure prophylaxis. Curr Top Microbiol Immunol (this issue)
158. Weniger BG, Papania MJ (2008) Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offit P (eds) Vaccines. Saunders Elsevier, Philadelphia, pp 1357-1392
159. Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA (1984) Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet 2:834-837 (Pubitemid 14015467)
160. WHO (2005) WHO expert consultation on rabies. WHO Tech Rep Ser 931:1-88
161. WHO (2007) Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 82:425-435
162. WHO (2010) WHO fact sheet: smallpox. WHO, Geneva. http://www.who.int/ mediacentre/factsheets/smallpox/en/14 Sept 2010
163. Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, Cormier M (2006) Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24:1653-1664 (Pubitemid 43238242)
164. Williams J, Fox-Leyva L, Christensen C, Fisher D, Schlicting E, Snowball M, Negus S, Mayers J, Koller R, Stout R (2000) Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 18:1939-1943 (Pubitemid 30122858)
165. Zhao YL, Murthy SN, Manjili MH, Guan LJ, Sen A, Hui SW (2006) Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 24:1282-1290 (Pubitemid 43222035)
166. Zhu QY, Zarnitsyn VG, Ye L, Wen ZY, Gao YL, Pan L, Skountzou I, Gill HS, Prausnitz MR, Yang CL, Compans RW (2009) Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA 106:7968-7973
167. Zoulek G, Roggendorf M, Deinhardt F (1984) Immune response to single dose, multisite, intradermal and to intramuscular administration of vaccine against tick-borne encephalitis virus. Lancet 2:584 (Pubitemid 14072087)
168. Zoulek G, Roggendorf M, Deinhardt F, Kunz C (1986) Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus. J Med Virol 19:55-61 (Pubitemid 16142972)